These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28938455)

  • 1. Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects.
    Legry V; Francque S; Haas JT; Verrijken A; Caron S; Chávez-Talavera O; Vallez E; Vonghia L; Dirinck E; Verhaegen A; Kouach M; Lestavel S; Lefebvre P; Van Gaal L; Tailleux A; Paumelle R; Staels B
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3783-3794. PubMed ID: 28938455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    Friedrich D; Marschall HU; Lammert F
    BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
    Hernandez GV; Smith VA; Melnyk M; Burd MA; Sprayberry KA; Edwards MS; Peterson DG; Bennet DC; Fanter RK; Columbus DA; Steibel JP; Glanz H; Immoos C; Rice MS; Santiago-Rodriguez TM; Blank J; VanderKelen JJ; Kitts CL; Piccolo BD; La Frano MR; Burrin DG; Maj M; Manjarin R
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G582-G609. PubMed ID: 32003601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    Mouzaki M; Wang AY; Bandsma R; Comelli EM; Arendt BM; Zhang L; Fung S; Fischer SE; McGilvray IG; Allard JP
    PLoS One; 2016; 11(5):e0151829. PubMed ID: 27203081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NASH-related increases in plasma bile acid levels depend on insulin resistance.
    Grzych G; Chávez-Talavera O; Descat A; Thuillier D; Verrijken A; Kouach M; Legry V; Verkindt H; Raverdy V; Legendre B; Caiazzo R; Van Gaal L; Goossens JF; Paumelle R; Francque S; Pattou F; Haas JT; Tailleux A; Staels B
    JHEP Rep; 2021 Apr; 3(2):100222. PubMed ID: 33615207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
    Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
    JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus.
    Jung Y; Koo BK; Jang SY; Kim D; Lee H; Lee DH; Joo SK; Jung YJ; Park JH; Yoo T; Choi M; Lee MK; Kang SW; Chang MS; Kim W; Hwang GS;
    Liver Int; 2021 Dec; 41(12):2892-2902. PubMed ID: 34358397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.
    Bechmann LP; Kocabayoglu P; Sowa JP; Sydor S; Best J; Schlattjan M; Beilfuss A; Schmitt J; Hannivoort RA; Kilicarslan A; Rust C; Berr F; Tschopp O; Gerken G; Friedman SL; Geier A; Canbay A
    Hepatology; 2013 Apr; 57(4):1394-406. PubMed ID: 23299969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women.
    Mercer KE; Maurer A; Pack LM; Ono-Moore K; Spray BJ; Campbell C; Chandler CJ; Burnett D; Souza E; Casazza G; Keim N; Newman J; Hunter G; Fernadez J; Garvey WT; Harper ME; Hoppel C; Adams SH; Thyfault J
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E864-E873. PubMed ID: 33645254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC.
    Sydor S; Best J; Messerschmidt I; Manka P; Vilchez-Vargas R; Brodesser S; Lucas C; Wegehaupt A; Wenning C; Aßmuth S; Hohenester S; Link A; Faber KN; Moshage H; Cubero FJ; Friedman SL; Gerken G; Trauner M; Canbay A; Bechmann LP
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00131. PubMed ID: 32352707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids.
    Puri P; Daita K; Joyce A; Mirshahi F; Santhekadur PK; Cazanave S; Luketic VA; Siddiqui MS; Boyett S; Min HK; Kumar DP; Kohli R; Zhou H; Hylemon PB; Contos MJ; Idowu M; Sanyal AJ
    Hepatology; 2018 Feb; 67(2):534-548. PubMed ID: 28696585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of supplemented isoenergetic diets varying in cereal fiber and protein content on the bile acid metabolic signature and relation to insulin resistance.
    Weickert MO; Hattersley JG; Kyrou I; Arafat AM; Rudovich N; Roden M; Nowotny P; von Loeffelholz C; Matysik S; Schmitz G; Pfeiffer AFH
    Nutr Diabetes; 2018 Mar; 8(1):11. PubMed ID: 29549243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin Modulates Bile Acid Homeostasis in Mice with Diet-Induced Nonalcoholic Steatohepatitis.
    Lastuvkova H; Faradonbeh FA; Schreiberova J; Hroch M; Mokry J; Faistova H; Nova Z; Hyspler R; Igreja Sa IC; Nachtigal P; Stefela A; Pavek P; Micuda S
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease.
    Lake AD; Novak P; Shipkova P; Aranibar N; Robertson D; Reily MD; Lu Z; Lehman-McKeeman LD; Cherrington NJ
    Toxicol Appl Pharmacol; 2013 Apr; 268(2):132-40. PubMed ID: 23391614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression.
    Nimer N; Choucair I; Wang Z; Nemet I; Li L; Gukasyan J; Weeks TL; Alkhouri N; Zein N; Tang WHW; Fischbach MA; Brown JM; Allayee H; Dasarathy S; Gogonea V; Hazen SL
    Metabolism; 2021 Mar; 116():154457. PubMed ID: 33275980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease.
    Okushin K; Tsutsumi T; Enooku K; Fujinaga H; Kado A; Shibahara J; Fukayama M; Moriya K; Yotsuyanagi H; Koike K
    J Gastroenterol; 2016 Aug; 51(8):808-18. PubMed ID: 26601667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.
    Tiessen RG; Kennedy CA; Keller BT; Levin N; Acevedo L; Gedulin B; van Vliet AA; Dorenbaum A; Palmer M
    BMC Gastroenterol; 2018 Jan; 18(1):3. PubMed ID: 29304731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population.
    Sepulveda-Villegas M; Roman S; Rivera-Iñiguez I; Ojeda-Granados C; Gonzalez-Aldaco K; Torres-Reyes LA; Jose-Abrego A; Panduro A
    PLoS One; 2019; 14(1):e0208926. PubMed ID: 30608932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of Bile Acid Profiles, GLP-1, and FGF19 After Laparoscopic Gastric Banding.
    Thöni V; Pfister A; Melmer A; Enrich B; Salzmann K; Kaser S; Lamina C; Ebenbichler CF; Hackl H; Tilg H; Moschen AR
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2974-2984. PubMed ID: 28591793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes.
    Chávez-Talavera O; Wargny M; Pichelin M; Descat A; Vallez E; Kouach M; Bigot-Corbel E; Joliveau M; Goossens JF; Le May C; Hadjadj S; Hanf R; Tailleux A; Staels B; Cariou B
    Metabolism; 2020 Feb; 103():154042. PubMed ID: 31785259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.